Nothing Special   »   [go: up one dir, main page]

MX354049B - Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados. - Google Patents

Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.

Info

Publication number
MX354049B
MX354049B MX2014007256A MX2014007256A MX354049B MX 354049 B MX354049 B MX 354049B MX 2014007256 A MX2014007256 A MX 2014007256A MX 2014007256 A MX2014007256 A MX 2014007256A MX 354049 B MX354049 B MX 354049B
Authority
MX
Mexico
Prior art keywords
cloning
antibody variable
expression
variable region
gene segments
Prior art date
Application number
MX2014007256A
Other languages
English (en)
Other versions
MX2014007256A (es
Inventor
Seeber Stefan
Kopetzki Erhard
Hoege Simone
Ostler Dominique
Tiefenthaler Georg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47522537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX354049(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2014007256A publication Critical patent/MX2014007256A/es
Publication of MX354049B publication Critical patent/MX354049B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Analytical Chemistry (AREA)

Abstract

La presente invención se refiere a un método como se reporta el aislamiento de segmentos de ácido nucleico que codifican para dominios variables de anticuerpo y la inserción de los segmentos aislados de ácido nucleico en plásmidos de expresión eucariótica se realiza sin el aislamiento y análisis intermedios de plásmidos clonales intermedios. De esta manera, en el método como se reporta en la presente, no se requieren la donación, aislamiento y análisis intermedios de plásmidos intermedios, por ejemplo, por análisis de células de E. coli, transformadas, aisladas.
MX2014007256A 2011-12-21 2012-12-19 Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados. MX354049B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194861 2011-12-21
PCT/EP2012/076155 WO2013092716A1 (en) 2011-12-21 2012-12-19 Rapid method for cloning and expression of cognate antibody variable region gene segments

Publications (2)

Publication Number Publication Date
MX2014007256A MX2014007256A (es) 2014-08-01
MX354049B true MX354049B (es) 2018-02-09

Family

ID=47522537

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007256A MX354049B (es) 2011-12-21 2012-12-19 Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.

Country Status (12)

Country Link
US (3) US20140302559A1 (es)
EP (1) EP2794652B1 (es)
JP (3) JP2015500655A (es)
KR (1) KR20140104963A (es)
CN (2) CN109810188A (es)
BR (1) BR112014013034A2 (es)
CA (1) CA2854243A1 (es)
HK (1) HK1199891A1 (es)
MX (1) MX354049B (es)
RU (1) RU2612910C2 (es)
SG (1) SG11201403365TA (es)
WO (1) WO2013092716A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2417156T3 (en) 2009-04-07 2015-03-02 Roche Glycart Ag Trivalent, bispecific antibodies
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
CN104945509A (zh) 2009-09-16 2015-09-30 弗·哈夫曼-拉罗切有限公司 包含卷曲螺旋和/或系链的蛋白质复合体及其用途
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
JP5758004B2 (ja) 2010-08-24 2015-08-05 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ジスルフィドによって安定化されたＦｖ断片を含む二重特異性抗体
JP5766296B2 (ja) 2010-12-23 2015-08-19 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
KR101638224B1 (ko) 2011-02-28 2016-07-08 에프. 호프만-라 로슈 아게 항원 결합 단백질
BR112013020338A2 (pt) 2011-02-28 2016-10-18 Hoffmann La Roche proteína de ligação de antígeno monovalente, composição farmacêutica, uso da proteína de ligação de antígeno monovalente, método para o tratamento de um paciente com necessidade de terapia, método para a preparação de uma proteína de ligação de antígeno monovalente, ácido nucleico, vetor e célula hospedeira
MX354049B (es) * 2011-12-21 2018-02-09 Hoffmann La Roche Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.
CA2861124A1 (en) 2012-02-10 2013-08-15 Genentech, Inc. Single-chain antibodies and other heteromultimers
JP6203838B2 (ja) 2012-06-27 2017-09-27 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 少なくとも２つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用
CA2871882A1 (en) 2012-06-27 2014-01-03 F. Hoffmann-La Roche Ag Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
US20160075766A1 (en) * 2013-05-21 2016-03-17 Roche Diagnostics Operations, Inc. Method for producing antibodies using ovine b-cells and uses thereof
CN105612182B (zh) 2013-10-11 2019-12-10 豪夫迈·罗氏有限公司 多特异性结构域交换共有可变轻链抗体
CN105283543A (zh) * 2014-05-19 2016-01-27 豪夫迈·罗氏有限公司 使用绵羊b细胞产生抗体的方法及其用途
EP3227332B1 (en) 2014-12-03 2019-11-06 F.Hoffmann-La Roche Ag Multispecific antibodies
EP3436571B1 (en) 2016-03-30 2023-06-14 F. Hoffmann-La Roche AG B-cell cultivation method
EP3559028A1 (en) * 2016-12-23 2019-10-30 Visterra, Inc. Binding polypeptides and methods of making the same
JP6916884B2 (ja) 2017-01-02 2021-08-11 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｂ細胞培養法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815909D0 (en) * 1998-07-21 1998-09-16 Btg Int Ltd Antibody preparation
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
US20060051348A1 (en) 2004-09-09 2006-03-09 Jorn Gorlach Method of producing a plurality of isolated antibodies to a plurality of cognate antigens
EP1928914A2 (en) 2005-09-15 2008-06-11 Crucell Holland B.V. Method for preparing immunoglobulin libraries
CA2652392C (en) 2006-05-19 2017-10-10 Alder Biopharmaceuticals, Inc. Culture method for obtaining a clonal population of antigen-specific b cells
LT2164514T (lt) 2007-05-21 2017-03-10 Alderbio Holdings Llc Il-6 antikūnai ir jų naudojimas
CN102272158B (zh) * 2008-11-12 2014-05-07 乔治·K·刘易斯 源自记忆b细胞的人单克隆抗体的快速表达克隆
US8609097B2 (en) * 2009-06-10 2013-12-17 Hoffmann-La Roche Inc. Use of an anti-Tau pS422 antibody for the treatment of brain diseases
WO2011057360A1 (en) * 2009-11-16 2011-05-19 Acyte Biotech Pty Ltd Recombinant antibody vector
US20110223176A1 (en) * 2010-03-11 2011-09-15 Abbott Laboratories Basigin binding proteins
PL2400298T3 (pl) * 2010-05-28 2014-01-31 Hoffmann La Roche Sposób hodowania pojedynczych komórek b oraz wytwarzania swoistych przeciwciał
MX354049B (es) * 2011-12-21 2018-02-09 Hoffmann La Roche Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.

Also Published As

Publication number Publication date
JP6573331B2 (ja) 2019-09-11
US20170210785A1 (en) 2017-07-27
WO2013092716A1 (en) 2013-06-27
KR20140104963A (ko) 2014-08-29
US20190382469A1 (en) 2019-12-19
JP2015500655A (ja) 2015-01-08
MX2014007256A (es) 2014-08-01
RU2014128987A (ru) 2016-02-20
US12024548B2 (en) 2024-07-02
BR112014013034A2 (pt) 2017-12-19
EP2794652B1 (en) 2017-11-15
US20140302559A1 (en) 2014-10-09
HK1199891A1 (en) 2015-07-24
RU2612910C2 (ru) 2017-03-13
EP2794652A1 (en) 2014-10-29
CN104011074A (zh) 2014-08-27
CA2854243A1 (en) 2013-06-27
JP2017221190A (ja) 2017-12-21
CN109810188A (zh) 2019-05-28
JP2019162144A (ja) 2019-09-26
SG11201403365TA (en) 2014-07-30

Similar Documents

Publication Publication Date Title
MX354049B (es) Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.
CA3062698A1 (en) Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
MX2014004598A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
EP4253534A3 (en) Alpha-amylase variants and polynucleotides encoding same
MX2015008446A (es) Composiciones de proteinas de union multivalentes.
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
MX337984B (es) Variantes de alfa amilasa y polinucleotidos que codifican la misma.
IN2014CN04586A (es)
MX353621B (es) Variantes de alfa-amilasa.
MX2021000211A (es) Metodos y productos para transfeccion de celulas.
EP3543333A3 (en) Method for screening alpha-amylases
AR088322A1 (es) Anticuerpos anti-htra1 y metodos de uso
MY170720A (en) Antibody formulations
EP3517611A3 (en) Methods for preparative in vitro cloning
EP3696265A3 (en) Lipase variants and polynucleotides encoding same
NZ730014A (en) Compound targeting il-23a and tnf-alpha and uses thereof
WO2013119302A3 (en) Gh61 polypeptide variants and polynucleotides encoding same
MX2020003508A (es) Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
UA105073C2 (uk) Антитіло проти фракталкіну, композиція і спосіб для лікування запальних порушень
PH12019501001A1 (en) Method for preparing electrocompetent yeast cells, and method for using said cells
MX2014007446A (es) Variantes de subtilasa y polinucleotidos que las codifican.
WO2013040548A3 (en) Fluoride-responsive riboswitchs, fluoride transporters, and methods of use
WO2012109470A3 (en) Mutant luciferases
WO2012175745A9 (en) Cell secreted proteins for the treatment of myocardial infarction

Legal Events

Date Code Title Description
FG Grant or registration